← Back to Bain Capital Life Sciences Profile
Bain Capital Life Sciences is a dedicated investment firm focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.
Bain Capital Life Sciences, founded in 2016, is a dedicated investment firm focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools. With over $7 billion in assets under management and a team of experts with deep industry and scientific insights, they aim to build a diverse portfolio of high-impact companies addressing unmet medical needs.
Bain Capital Life Sciences is located in Boston, United States.
Bain Capital Life Sciences was founded in 2016.
Bain Capital Life Sciences is a venture capital firm.
The typical check size for Bain Capital Life Sciences is $12,500,000 USD.
No, Bain Capital Life Sciences does not accept cold outreach.
Key team members at Bain Capital Life Sciences include Allyson S. Rinderle, Ricky Lijing Sun, and Matthew Calistri.
Verification Confidence: 95% | Source: summary | Entity: Bain Capital Life Sciences